Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplastic Cells, Circulating 2Colorectal Neoplasms 2Neoplasms 1Neoplasm, Residual 1Colonic Neoplasms 1

Interventions

Blood Specimen Collection 9Liquid Biopsy 4cabazitaxel 3Trastuzumab 3Surgical Procedures, Operative 3Propofol 3Bevacizumab 3Standard of Care 2Spinal Puncture 2Sevoflurane 2Positron Emission Tomography Computed Tomography 2Pirinitramide 2Morphine 2Laparoscopy 2Folfox protocol 2Epirubicin 2Drug Therapy 2Cyclophosphamide 2Cetuximab 2Carboplatin 2Aspirin 2Anesthesia, General 2ribociclib 1pertuzumab 1osimertinib 1jinfukang 1eribulin 1Zoledronic Acid 1Vinorelbine 1Thiotepa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplastic Cells, Circulating × Pirinitramide × Clear all
NCT03700411 2023-12-07

POACC-1

The Institute of Molecular and Translational Medicine, Czech Republic

Phase 4 Completed
125 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Colorectal Neoplasms

NCT03700541 2023-12-07

POACC-2

The Institute of Molecular and Translational Medicine, Czech Republic

Phase 4 Completed
71 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡